Event Date/Time: Oct 27, 2008 End Date/Time: Oct 29, 2008
Registration Date: Oct 24, 2008
Early Registration Date: Sep 19, 2008
Report as Spam


This Pharma IQ conference is essential for scientists in drug discovery who wish to understand how to identify poorly soluble drugs. Avoiding unnecessary formulation development costs, accelerating timelines, expanding pipelines, establishing effective research investments, and incorporating the correct strategy are all vital for scientists to produce and develop bioavailable drugs.

This conference, now back in the U.S., will provide the necessary updates, cutting edge science, strategies, and technologies incorporated by other companies that will enable you to find out what best practice is for you!

Topics of discussion include:
• Actively seek new and improved ways to understand the importance of solubility in exposure during preclinical and clinical phases, and what parameters to control
• Avoid overcomplicating preclinical and clinical exposure issues
• Identifying compounds that will have issues during preclinical and clinical phases, and what you can do
• Build a higher probability of a new drug passing through the development pipeline
• Build an effective research strategy for the unique properties of a molecule
• Improve efficiency and throughput in testing compounds and develop good strategies to deal with this in formulation